Combining a WT1 Vaccine (Galinpepimut-S) with Checkpoint Inhibition (nivolumab) in Patients with WT1-Expressing Diffuse Pleural Mesothelioma (DPM): A Phase I Study
JTO Clinical and Research Reports（2024）
Key words
Mesothelioma,Cancer vaccines,Immunotherapy,Phase 1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined